Company page

Inflarx N.v.

Inflarx N.V. is a public company traded under the ticker IFRX in the American market, with a market capitalization of approximately $266.6 million. The company focuses on developing innovative therapies for inflammatory diseases. Its research and development efforts aim to address unmet medical needs in this area.